BioCardia (BCDA) Cash from Investing Activities (2010 - 2026)

BioCardia (BCDA) has reported Cash from Investing Activities for 14 consecutive years, with -$3000.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$3000.0 in Q1 2026; TTM through Jun 2026 was -$9000.0, a 125.0% decrease from a year earlier, with the FY2025 full-year figure at -$7000.0, down 16.67% from the prior year.
• Cash from Investing Activities was -$3000.0 for Q1 2026 at BioCardia, up from -$6000.0 in the prior quarter.
• Over five years, Cash from Investing Activities peaked at -$1000.0 in Q4 2024 and troughed at -$29000.0 in Q1 2022.
• A 5-year average of -$8166.7 and a median of -$3000.0 in 2024 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities soared 95.12% in 2022 and slumped 500.0% in 2025, its largest moves.
• Over 5 years, Cash from Investing Activities stood at -$2000.0 in 2022, then changed by 0.0% to -$2000.0 in 2023, then surged by 50.0% to -$1000.0 in 2024, then tumbled by 500.0% to -$6000.0 in 2025, then surged by 50.0% to -$3000.0 in 2026.
• The last three Cash from Investing Activities figures came in at -$3000.0 (Q1 2026), -$6000.0 (Q4 2025), and -$1000.0 (Q2 2025), per Business Quant data.